Avtor/Urednik		Matičič, Mojca; Poljak, Mario
Naslov		Slovenske nacionalne usmeritve za preprečevanje reaktivacije hepatitisa B pri bolnikih, ki potrebujejo imunosupresivno zdravljenje
Prevedeni naslov		Slovene national guidelines for the prevention of hepatitis B reactivation in patients undergoing immunosuppressive therapy
Tip		članek
Vir		Zdrav Vestn
Vol. in št.		Letnik 79, št. 9
Leto izdaje		2010
Obseg		str. 599-608
Jezik		slo
Abstrakt		Chronic hepatitis B virus infection as well as the presence of a past viral infection may lead to the reactivation of hepatitis B in patients undergoing immunosuppressive therapy due to some underlying diseases. Prompt introduction of a preemptive treatment or chemoprophylaxis may successfully prevent the viral reactivation. For that reason, screening for hepatitis B virus infection prior to the introduction of immunosuppressive therapy is crucial for the management of hepatitis B reactivation. The pathogenesis, risk factors and clinical course of hepatitis B reactivation in patients undergoing immunosuppressive therapy, as well as antiviral agents and the national guidelines for its prevention are presented.
Deskriptorji		HEPATITIS B IMMUNOSUPPRESSIVE AGENTS VIRUS ACTIVATION CHEMOPREVENTION PRACTICE GUIDELINES SLOVENIA